evolcSign inStart free
Menu

Integral Molecular

Biotechnology products and research services for membrane-protein drug discovery, antibody development, and vaccine research

United Statesintegralmolecular.comWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-13

Recent signals

What changed at Integral Molecular in the last 6 months, newest first. Each line links to its public source.

Get signals like these for the companies you sell to →

About Integral Molecular

Integral Molecular develops technologies and therapeutic antibodies for difficult membrane-protein targets, including GPCRs, ion channels, transporters, and viral envelopes. Its offerings include antibody discovery, epitope mapping, membrane proteome arrays, virology tools, and lipoparticles.

It serves pharmaceutical and biotechnology companies and other organizations involved in research, drug discovery, and vaccine development, through products, research services, and therapeutic asset licensing. The company was co-founded in 2001 and is based in Philadelphia, where it operates a research facility.

Product: Membrane-protein research products and services, therapeutic antibody discovery, and antibody assets available for licensing.

Jobs at Integral Molecular

No open positions listed right now.

More biotech & pharma companies

  • Invivyd

    Develops antibody medicines for prevention and treatment of serious viral diseases, including COVID-19
    United StatesBiotech & pharma
    New on Evolc

  • Isbscience

    Biomedical research institute studying complex biological systems to improve human health and disease treatment
    United StatesBiotech & pharma
    New on Evolc

  • Jade Biosciences

    Developing monoclonal antibody therapies for patients with serious autoimmune diseases
    United StatesBiotech & pharma
    New on Evolc

  • Jsrglobal

    Contract development and cGMP manufacturing of biologics, plus analytical testing, for biopharmaceutical companies
    United StatesBiotech & pharmaFounded 19962 open jobs
    Remote-friendlySalary transparent

  • Kardigan

    Develops targeted cardiovascular medicines for patients with heart and vascular diseases
    United StatesBiotech & pharma

  • Kura Oncology

    Develops targeted precision cancer therapies for head and neck cancer, lung cancer and acute leukemias
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google Tag ManagerMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

CRM & customer data

  • HubSpotHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Contact Form 7High confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Google reCAPTCHAHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Marketing & advertising

  • Google AdsHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • LinkedIn InsightMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Recruiting

  • GreenhouseHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.